230 related articles for article (PubMed ID: 23876130)
1. Current strategies for the treatment of complicated intraabdominal infections.
Skrupky LP; Tellor BR; Mazuski JE
Expert Opin Pharmacother; 2013 Oct; 14(14):1933-47. PubMed ID: 23876130
[TBL] [Abstract][Full Text] [Related]
2. Resistance mechanisms and epidemiology of multiresistant pathogens in Europe and efficacy of tigecycline in observational studies.
Heizmann WR; Dupont H; Montravers P; Guirao X; Eckmann C; Bassetti M; García MS; Capparella MR; Simoneau D; Bodmann KF
J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii45-55. PubMed ID: 23772046
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and Risk Factors for Isolation of Multi-Drug-Resistant Organisms in Patients with Complicated Intra-Abdominal Infections.
Labricciosa FM; Sartelli M; Abbo LM; Barbadoro P; Ansaloni L; Coccolini F; Catena F
Surg Infect (Larchmt); 2018 Apr; 19(3):264-272. PubMed ID: 29298133
[TBL] [Abstract][Full Text] [Related]
4. New drugs for the treatment of complicated intra-abdominal infections in the era of increasing antimicrobial resistance.
Syue LS; Chen YH; Ko WC; Hsueh PR
Int J Antimicrob Agents; 2016 Apr; 47(4):250-8. PubMed ID: 27005457
[TBL] [Abstract][Full Text] [Related]
5. Clinical challenges and unmet needs in the management of complicated intra-abdominal infections.
Mazuski JE
Surg Infect (Larchmt); 2005; 6 Suppl 2():S-49-69. PubMed ID: 23577497
[TBL] [Abstract][Full Text] [Related]
6. Recent developments in antibiotic agents for the treatment of complicated intra-abdominal infections.
Lin SY; Huang CH; Ko WC; Chen YH; Hsueh PR
Expert Opin Pharmacother; 2016; 17(3):339-54. PubMed ID: 26610040
[TBL] [Abstract][Full Text] [Related]
7. New antimicrobial options for the management of complicated intra-abdominal infections.
Leone S; Damiani G; Pezone I; Kelly ME; Cascella M; Alfieri A; Pace MC; Fiore M
Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):819-827. PubMed ID: 30903538
[TBL] [Abstract][Full Text] [Related]
8. Clinical update on the use of moxifloxacin in the treatment of community-acquired complicated intraabdominal infections.
Cheadle W; Lee JT; Napolitano LM; Nichols RL
Surg Infect (Larchmt); 2010 Oct; 11(5):487-94. PubMed ID: 20583956
[TBL] [Abstract][Full Text] [Related]
9. Intra-abdominal infections: model of antibiotic stewardship in an era with limited antimicrobial options.
Leone S; Stefani S; Venditti M; Grossi P; Colizza S; De Gasperi A; Scaglione F; Sganga G; Esposito S;
Int J Antimicrob Agents; 2011 Sep; 38(3):271-2. PubMed ID: 21782394
[No Abstract] [Full Text] [Related]
10. Epidemiological study of community- and hospital-acquired intraabdominal infections.
Zhang S; Huang W
Chin J Traumatol; 2015; 18(2):84-9. PubMed ID: 26511299
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studies.
Eckmann C; Montravers P; Bassetti M; Bodmann KF; Heizmann WR; Sánchez García M; Guirao X; Capparella MR; Simoneau D; Dupont H
J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii25-35. PubMed ID: 23772043
[TBL] [Abstract][Full Text] [Related]
12. Eravacycline for the treatment of intra-abdominal infections.
Bassetti M; Righi E
Expert Opin Investig Drugs; 2014 Nov; 23(11):1575-84. PubMed ID: 25251475
[TBL] [Abstract][Full Text] [Related]
13. Complicated Intra-Abdominal Infections: The Old Antimicrobials and the New Players.
Lee YR; McMahan D; McCall C; Perry GK
Drugs; 2015 Dec; 75(18):2097-117. PubMed ID: 26612473
[TBL] [Abstract][Full Text] [Related]
14. [Intraabdominal infections].
Adámková V
Klin Mikrobiol Infekc Lek; 2017 Jun; 23(2):64-75. PubMed ID: 28903171
[TBL] [Abstract][Full Text] [Related]
15. Safety and tolerability of tigecycline for the treatment of complicated skin and soft-tissue and intra-abdominal infections: an analysis based on five European observational studies.
Guirao X; Sánchez García M; Bassetti M; Bodmann KF; Dupont H; Montravers P; Heizmann WR; Capparella MR; Simoneau D; Eckmann C
J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii37-44. PubMed ID: 23772045
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial de-escalation strategies in hospitalized patients with pneumonia, intra-abdominal infections, and bacteremia.
Kaye KS
J Hosp Med; 2012; 7 Suppl 1():S13-21. PubMed ID: 23737333
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial de-escalation strategies in hospitalized patients with pneumonia, intra-abdominal infections, and bacteremia.
Kaye KS
J Hosp Med; 2012; 7 Suppl 1():S13-21. PubMed ID: 23677630
[TBL] [Abstract][Full Text] [Related]
18. Empiric antibiotic selection strategies for healthcare-associated pneumonia, intra-abdominal infections, and catheter-associated bacteremia.
Snydman DR
J Hosp Med; 2012; 7 Suppl 1():S2-S12. PubMed ID: 23737334
[TBL] [Abstract][Full Text] [Related]
19. Empiric antibiotic selection strategies for healthcare-associated pneumonia, intra-abdominal infections, and catheter-associated bacteremia.
Snydman DR
J Hosp Med; 2012; 7 Suppl 1():S2-12. PubMed ID: 23677631
[TBL] [Abstract][Full Text] [Related]
20. Clinical and microbiological efficacy of tigecycline for complicated skin-soft-tissue and intra-abdominal infections in a Turkish university hospital.
Avkan-Oguz V; Yapar N; Alp-Cavus S; Demir Onder K; Aktas E; Gulay Z; Cakır N
Int J Clin Pract; 2013 Jun; 67(6):505-11. PubMed ID: 23679904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
